Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
WIL Research Company Selects Q Exactive Mass Spectrometer
Thursday, June 28, 2012
HR/AM capability to expand the company’s regulated bioanalysis, drug discovery and metabolism/structural identification services.

Metabolon’s Quantose™ IR Test Featured in Five Poster Presentations at 2012 ADA Meeting
Tuesday, June 12, 2012
Clinical data demonstrate test’s effectiveness in stratifying prediabetic patients based on insulin resistance levels.

Thermo Scientific Announces Expanded Portfolio of Applications Software for the Q Exactive Mass Spectrometer
Friday, June 08, 2012
High-performance quadrupole-Orbitrap mass analysis and applications software unite to increase the speed and confidence in a wide range of quantitative and qualitative workflows.

Bio-Rad Introduces First ProteOn™ Sensor Chip
Thursday, May 24, 2012
Product capable of label-free interaction analysis of membrane proteins with peptides and small molecules.

MSc2™ from LECO
Monday, May 07, 2012
Mass spectrometry with comprehensive collision-induced dissociation.

Thermo Scientific Debuts High-Performance Benchtop Quadrupole-Orbitrap Mass Spectrometer
Monday, March 26, 2012
Thermo Scientific Q Exactive is a compelling alternative to Q-TOF.

AB SCIEX Launches New Workhorse Mass Spectrometer for Routine Quantitation and Screening
Tuesday, March 20, 2012
AB SCIEX 4500 series delivers 10x better sensitivity over competitors’ triple quadrupoles in the same class.

Gilson Announces the Release of PIPETMAN® M Multichannel
Thursday, December 15, 2011
New PIPETMAN M Multichannel requires no learning curve, and simplifies daily work.

LECO Corporation to Host Free Webinar on Identifying Ergogenic Aids and Metabolites in Urine
Monday, September 26, 2011
LECO Corporation to host free webinar on Wednesday, October 26, at 11 a.m. EST.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 330
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv